Advertisement

Vasospastic Angina

  • Edina Cenko
  • Raffaele BugiardiniEmail author
Chapter

Abstract

Vasospastic angina is a form of ischemic heart disease caused by episodes of coronary artery increased focal vasomotor tone occurring typically at rest. Clinically episodes will manifest as angina at rest associated with ST-segment changes on the electrocardiogram (ECG) and promptly relieved by calcium channel antagonist (CCB) or short-acting nitrates. In recent years studies have demonstrated that coronary spasm can occur during physical or emotional stress and episodes could be associated with ST-segment depression on the ECG. Diffuse coronary artery spasm, characterizing vasotonic angina, is a manifestation of endothelial dysfunction involving the entire coronary tree and the coronary microcirculation is the major culprit. These patients will present with symptoms of stable and unstable angina and ST-segment depression on the ECG.

Keywords

Coronary artery disease Vasospastic angina Vasotonic angina Epicardial vasoconstriction Diffuse coronary spasm Focal coronary spasm 

References

  1. 1.
    Osler W. The lumleian lectures on angina pectoris. Lancet. 1910;175(4517):839–44.CrossRefGoogle Scholar
  2. 2.
    Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med. 1959;27:375–88.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Maseri A, Severi S, Nes MD, L’Abbate A, Chierchia S, Marzilli M, Ballestra AM, Parodi O, Biagini A, Distante A. “Variant” angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. Am J Cardiol. 1978;42(6):1019–35.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Bugiardini R, Pozzati A, Ottani F, Morgagni GL, Puddu P. Vasotonic angina: a spectrum of ischemic syndromes involving functional abnormalities of the epicardial and microvascular coronary circulation. J Am Coll Cardiol. 1993;22(2):417–25.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. Circ J. 2010;74(8):1745–62.CrossRefGoogle Scholar
  6. 6.
    Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation. 2004;109(21):2518–23.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Bugiardini R, Borghi A, Biagetti L, Puddu P. Comparison of verapamil versus propranolol therapy in syndrome X. Am J Cardiol. 1989;63(5):286–90.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    MacAlpin RN. Relation of coronary arterial spasm to sites of organic stenosis. Am J Cardiol. 1980;46(1):143–53.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Manfrini O, Pizzi C, Trerè D, Fontana F, Bugiardini R. Parasympathetic failure and risk of subsequent coronary events in unstable angina and non-ST-segment elevation myocardial infarction. Eur Heart J. 2003;24(17):1560–6.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Cenko E, Bugiardini R. Vasotonic angina as a cause of myocardial ischemia in women. Cardiovasc Drugs Ther. 2015;29(4):339–45.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Khuddus MA, Pepine CJ, Handberg EM, Bairey Merz CN, Sopko G, Bavry AA, Denardo SJ, McGorray SP, Smith KM, Sharaf BL, Nicholls SJ, Nissen SE, Anderson RD. An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, lung and blood institute-sponsored Women’s ischemia syndrome evaluation (WISE). J Interv Cardiol. 2010;23(6):511–9.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Manfrini O, Bazzocchi G, Luati A, Borghi A, Monari P, Bugiardini R. Coronary spasm reflects inputs from adjacent esophageal system. Am J Physiol Heart Circ Physiol. 2006;290(5):H2085–91.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Bertrand ME, Lablanche JM, Rousseau MF, Warembourg HH, Stankowtak C, Soots G. Surgical treatment of variant angina: use of plexectomy with aortocoronary bypass. Circulation. 1980;61(5):877–82.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Betriu A, Pomar JL, Bourassa MG, Grondin CM. Influence of partial sympathetic denervation on the results of myocardial revascularization in variant angina. Am J Cardiol. 1983;51(5):661–7.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Miller D, Waters DD, Warnica W, Szlachcic J, Kreeft J, Théroux P. Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med. 1981;304(13):763–6.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology. 2007;68(19):1563–70.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KR, Quyyumi AA. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106(6):653–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101(9):948–54.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Manfrini O, Cenko E, Verna E, Salerno Uriarte JA, Bugiardini R. Endothelial dysfunction versus early atherosclerosis: a study with high resolution imaging. Int J Cardiol. 2013;168(2):1714–6.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81(2):491–7.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Pries AR, Badimon L, Bugiardini R, Camici PG, Dorobantu M, Duncker DJ, Escaned J, Koller A, Piek JJ, de Wit C. Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. Eur Heart J. 2015;36(45):3134–46.PubMedCrossRefGoogle Scholar
  22. 22.
    Bugiardini R, Cenko E. A short history of vasospastic angina. J Am Coll Cardiol. 2017;70(19):2359–62.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Zeiher AM, Drexler H, Wollschlaeger H, Saurbier B, Just H. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol. 1989;14(5):1181–90.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Bugiardini R, Badimon L, Collins P, Erbel R, Fox K, Hamm C, Pinto F, Rosengren A, Stefanadis C, Wallentin L, Van de Werf F. Angina, “normal” coronary angiography, and vascular dysfunction: risk assessment strategies. PLoS Med. 2007;4(2):e12.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Badimon L, Bugiardini R, Cenko E, Cubedo J, Dorobantu M, Duncker DJ, Estruch R, Milicic D, Tousoulis D, Vasiljevic Z, Vilahur G, De Wit C, Koller A. Position paper of the European Society of Cardiology-working group of coronary pathophysiology andmicrocirculation: obesity and heart disease. Eur Heart J. 2017;38(25):1951–8.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA study (abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol. 2012;59(7):655–62.PubMedCrossRefGoogle Scholar
  27. 27.
    Crea F, Davies G, Chierchia S, Romeo F, Bugiardini R, Kaski JC, Freedman B, Maseri A. Different susceptibility to myocardial ischemia provoked by hyperventilation and cold pressor test in exertional and variant angina pectoris. Am J Cardiol. 1985;56(1):18–22.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Vrints CJ, Bult H, Hitter E, Herman AG, Snoeck JP. Impaired endothelium-dependent cholinergic coronary vasodilation in patients with angina and normal coronary arteriograms. J Am Coll Cardiol. 1992;19(1):21–31.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Bugiardini R, Bairey Merz CN. Angina with “normal” coronary arteries: a changing philosophy. JAMA. 2005;293(4):477–84.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Rosano GM, Peters NS, Kaski JC, Mavrogeni SI, Collins P, Underwood RS, Poole-Wilson PA. Abnormal uptake and washout of thallium-201 in patients with syndrome X and normal-appearing scans. Am J Cardiol. 1995;75(5):400–2.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, Pennell DJ. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346(25):1948–53.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Bugiardini R, Borghi A, Sassone B, Pozzati A, Puddu P. Prognostic significance of silent myocardial ischemia in variant angina pectoris. Am J Cardiol. 1991;68(17):1581–6.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Araki H, Koiwaya Y, Nakagaki O, Nakamura M. Diurnal distribution of ST-segment elevation and related arrhythmias in patients with variant angina: a study by ambulatory ECG monitoring. Circulation. 1983;67(5):995–1000.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Pozzati A, Pancaldi LG, Di Pasquale G, Pinelli G, Bugiardini R. Transient sympathovagal imbalance triggers “ischemic” sudden death in patients undergoing electrocardiographic Holter monitoring. J Am Coll Cardiol. 1996;27(4):847–52.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Waters DD, Szlachcic J, Bourassa MG, Scholl JM, Théroux P. Exercise testing in patients with variant angina: results, correlation with clinical and angiographic features and prognostic significance. Circulation. 1982;65(2):265–74.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    de Servi S, Falcone C, Gavazzi A, Mussini A, Bramucci E, Curti MT, Vecchio C, Specchia G, Bobba P. The exercise test in variant angina: results in 114 patients. Circulation. 1981;64(4):684–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Minoda K, Yasue H, Kugiyama K, Okumura K, Motomura K, Shimomura O, Takahashi M. Comparison of the distribution of myocardial blood flow between exercise-induced and hyperventilation-induced attacks of coronary spasm: a study with thallium-201 myocardial scintigraphy. Am Heart J. 1994;127(6):1474–80.PubMedCrossRefGoogle Scholar
  38. 38.
    Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Lerman A, Quyyumi AA, Sopko G, Investigators W. Insights from the NHLBI-sponsored Women’s ischemia syndrome evaluation (WISE) study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47(3 Suppl):S21–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Shaw LJ, Merz CN, Pepine CJ, Reis SE, Bittner V, Kip KE, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Sopko G. Investigators WsISEW. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women’s ischemia syndrome evaluation. Circulation. 2006;114(9):894–904.PubMedCrossRefGoogle Scholar
  40. 40.
    Bugiardini R, Manfrini O, De Ferrari GM. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med. 2006;166(13):1391–5.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Vaccarino V, Badimon L, Corti R, de Wit C, Dorobantu M, Manfrini O, Koller A, Pries A, Cenko E, Bugiardini R. Presentation, management, and outcomes of ischaemic heart disease in women. Nat Rev Cardiol. 2013;10(9):508–18.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Britten MB, Zeiher AM, Schächinger V. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coron Artery Dis. 2004;15(5):259–64.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Vaccarino V, Badimon L, Corti R, de Wit C, Dorobantu M, Hall A, Koller A, Marzilli M, Pries A, Bugiardini R. Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European society of cardiology. Cardiovasc Res. 2011;90(1):9–17.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Braun LT. Calcium channel blockers for the treatment of coronary artery spasm: rationale, effects, and nursing responsibilities. Heart Lung. 1983;12(3):226–32.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, Omote S, Takaoka K, Okumura K. Long-term prognosis for patients with variant angina and influential factors. Circulation. 1988;78(1):1–9.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Lombardi M, Morales MA, Michelassi C, Moscarelli E, Distante A, L’Abbate A. Efficacy of isosorbide-5-mononitrate versus nifedipine in preventing spontaneous and ergonovine-induced myocardial ischaemia. A double-blind, placebo-controlled study. Eur Heart J. 1993;14(6):845–51.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Robertson RM, Wood AJ, Vaughn WK, Robertson D. Exacerbation of vasotonic angina pectoris by propranolol. Circulation. 1982;65(2):281–5.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Cannon CPBE. Unstable angina and non-ST elevation myocardial infarction. 8th ed. Philadelphia: Saunders Elsevier; 2008.Google Scholar
  49. 49.
    Satake K, Lee JD, Shimizu H, Ueda T, Nakamura T. Relation between severity of magnesium deficiency and frequency of anginal attacks in men with variant angina. J Am Coll Cardiol. 1996;28(4):897–902.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G. The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest. 2000;118(6):1690–5.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Pizzi C, Manfrini O, Fontana F, Bugiardini R. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme a reductase in cardiac syndrome X: role of superoxide dismutase activity. Circulation. 2004;109(1):53–8.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Manfrini O, Pizzi C, Morgagni G, Fontana F, Bugiardini R. Effect of pravastatin on myocardial perfusion after percutaneous transluminal coronary angioplasty. Am J Cardiol. 2004;93(11):1391–3, A6.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, Ogawa H, Tayama S, Honda T, Hokimoto S, Ohshima S, Hokamura Y, Kugiyama K, Horie M, Yoshimura M, Harada M, Uemura S, Saito Y. Investigators SSaCAST. Effects of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol. 2008;51(18):1742–8.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Miwa K, Kambara H, Kawai C. Effect of aspirin in large doses on attacks of variant angina. Am Heart J. 1983;105(2):351–5.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Sueda S, Suzuki J, Watanabe K, Mineoi K, Kondou T, Yano K, Ochi T, Ochi N, Kawada H, Hayashi Y, Uraoka A. Comparative results of coronary intervention in patients with variant angina versus those with non-variant angina. Jpn Heart J. 2001;42(6):657–67.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Tanabe Y, Itoh E, Suzuki K, Ito M, Hosaka Y, Nakagawa I, Kumakura M. Limited role of coronary angioplasty and stenting in coronary spastic angina with organic stenosis. J Am Coll Cardiol. 2002;39(7):1120–6.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Corcos T, David PR, Bourassa MG, Val PG, Robert J, Mata LA, Waters DD. Percutaneous transluminal coronary angioplasty for the treatment of variant angina. J Am Coll Cardiol. 1985;5(5):1046–54.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Gaspardone A, Tomai F, Versaci F, Ghini AS, Polisca P, Crea F, Chiariello L, Gioffrè PA. Coronary artery stent placement in patients with variant angina refractory to medical treatment. Am J Cardiol. 1999;84(1):96–8, A8.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Matsue Y, Suzuki M, Nishizaki M, Hojo R, Hashimoto Y, Sakurada H. Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia. J Am Coll Cardiol. 2012;60(10):908–13.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Experimental, Diagnostic and Specialty MedicineUniversity of BolognaBolognaItaly

Personalised recommendations